Ajanta Pharma Q4 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,509.00
2.75 (0.08%)
2.75 (0.08%)Volume2.80 K
Updated: Wed 16 Sep, 2026 | 15:27:18
NSE
3,52413.60 (0.39%)
13.60 (0.39%)Volume1.16 L
Updated: Wed 16 Sep, 2026 | 15:29:49
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,133.60 | 1,036.11 | 9.41% | 810.01 | 24.16% |
| Depreciation/ Amortization | 45.37 | 43.51 | 4.27% | 34.25 | 14.05% |
| Operating Income | 288.04 | 338.73 | -14.96% | 244.07 | 11.92% |
| Net Income | 266.70 | 273.77 | -2.58% | 202.72 | 18.40% |
| Other Operating Expenses Total | 442.70 | 375.82 | 17.80% | 277.87 | 42.78% |
| Net Income Before Taxes | 347.11 | 358.60 | -3.20% | 278.04 | 28.84% |
| Total Revenue | 1,421.64 | 1,374.84 | 3.40% | 1,054.08 | 21.47% |
| Selling/ General/ Admin Expenses Total | 340.72 | 330.52 | 3.09% | 233.51 | 21.78% |
| Diluted Normalized EPS | 21.34 | 21.91 | -2.59% | 16.09 | 18.33% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.